已收录 268921 条政策
 政策提纲
  • 暂无提纲
High Content Imaging and Analysis Enable QuantitativeIn SituAssessment of CYP3A4 Using Cryopreserved Differentiated HepaRG Cells
[摘要] High-throughput imaging-based hepatotoxicity studies capable of analyzing individual cellsin situhold enormous promise for drug safety testing but are frequently limited by a lack of sufficient metabolically competent human cells. This study examined cryopreserved HepaRG cells, a human liver cell line which differentiates into both hepatocytes and biliary epithelial cells, to determine if these cells may represent a suitable metabolically competent cellular model for novel High Content Analysis (HCA) applications. Characterization studies showed that these cells retain many features characteristic of primary human hepatocytes and display significant CYP3A4 and CYP1A2 induction, unlike the HepG2 cell line commonly utilized for HCA studies. Furthermore, this study demonstrates that CYP3A4 induction can be quantified via a simple image analysis-based method, using HepaRG cells as a model system. Additionally, data demonstrate that the hepatocyte and biliary epithelial subpopulations characteristic of HepaRG cultures can be separated during analysis simply on the basis of nuclear size measurements. Proof of concept studies with fluorescent cell function reagents indicated that further multiparametric image-based assessment is achievable with HepaRG. In summary, image-based screening of metabolically competent human hepatocyte models cells such as HepaRG offers novel approaches for hepatotoxicity assessment and improved drug screening tools.
[发布日期]  [发布机构] 
[效力级别]  [学科分类] 药学
[关键词]  [时效性] 
   浏览次数:2      统一登录查看全文      激活码登录查看全文